Behavioral Health

Community HealthFirst and our providers are responsible for keeping members well, both body and mind. We provide care for our members across the full continuum of physical and behavioral health services.

Your Responsibilities as a Provider

As a primary care provider, you are responsible for coordinating with your patient’s behavioral health provider. You do not need to submit a referral for your patient’s mental health or substance use treatment. If you need help finding an appropriate behavioral health provider for your patient, please call CHPW, or direct your patient to call on their own behalf. No referral is required to see a mental health provider.

As a Behavioral Health Provider in an Integrated Managed Care (IMC) region, you are responsible for conducting an initial assessment for first-time patients to assess their level of need. You will coordinate with your patient’s primary care provider to create an appropriate care plan.

If you are a Behavioral Health Provider in a non-IMC region, you are responsible for conducting an initial assessment to determine treatment needs. You must also assess whether they meet Washington’s Access to Care Standards, and secure follow-up appointments with an appropriate behavioral health provider.

CHPW Will Ensure Access to Care

Providers seeking mental health treatment for their CHPW patients are no longer burdened with making multiple calls. CHPW has a new Customer Service process to take on the responsibility of ensuring access to an appropriate mental health providers for members. Simply, instruct members to call customer service if they need help finding a mental health provider. Care management staff that will identify available providers in the area and secire an appointment for your patient.

The new CHPW process is designed to reduce challenges faced by members who are searching for mental health provider. Since primary care providers often help patients access specialty services, including behavioral health, we want to let providers know about the new process for members to call Community Health Plan of Washington customer service.

Multichronic Care Management (MCCM)

MCCM is available for high‐risk members with multiple chronic conditions exacerbated by behavioral comorbidities and psychosocial challenges. MCCM focuses on addressing physical, psychological, and social drivers of maladaptive behavior. This helps members increase motivation, adhere to treatment, and achieve their personal health goals. Contact the Care Management team for more information or to refer a member.

Summary of Services

Psychiatric & Substance Use Disorder

  • Acute Psychiatric Inpatient
  • Evaluation & Treatment
  • Inpatient Acute Withdrawal (Detoxification)
  • Crisis Stabilization in a residential setting
  • Substance Use Disorder inpatient rehabilitation and residential treatment center
  • Psychiatric inpatient residential treatment center
  • Any facility-based service providing 24 hours/day and 7 days per week services

High-Intensity Outpatient Programs

  • Intensive Outpatient Program (IOP)
  • Partial Hospitalization Program (PHP)
  • Day Treatment Program

Community Support Services

  • SUD Recovery Services
  • Psychosocial Case Management/other Case Management services
  • Psychosocial Rehabilitation
  • Peer Support

Psychological and Neuropsychological Testing

Psychological and Neuropsychological testing requires prior authorization and notification.

➔ Download the request form before administering treatment

➔ Review our Medical Management policy on neuropsychological testing

Repetitive Transcranial Magnetic Stimulation

➔ Click here to view billing codes and notes for pre-authorized services

DID YOU KNOW...?

DRUG RECALL: VALSARTAN, VALSARTAN-HYDROCLOROTHIAZIDE & AMLODIPINE – VALSARTAN

Group of doctors and nurses looking to and discussing x-ray image at clinic.On 12/31/2018, Aurobindo Pharma USA, Inc. recalled Amlodipine-Valsartan, Valsartan-HCTZ, and Valsartan tablets due to the detection of trace amounts of an unexpected impurity found in the finished drug product.   To date, Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall.

Recalled Drug: Valsartan 320mg tablets, Amlodipine-Valsartan 5/160mg, 5/320mg, 10/160mg,    10/320mg tablets , and Valsartan & Hydrochlorothiazide 80/12.5mg, 160/12.5mg, 160/25mg, 320/12.5mg and 320/25mg tablets

Lot Numbers: Aurobindo Pharma USA, Inc. has 80 different lots of medications affected in this recall. Please refer to the link above for more information on the National Drug Code (NDC), expiration date and lot number that corresponds with your medication. More information about the recall is available at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.

☏ HAVE QUESTIONS ?

Sales Team

Get real answers
from real people

Phone: 1-800-944-1247
Email: Sales@chpw.org

x